Last quarter (Q4 2023), Protagonist Therapeutics's total revenue was $60.00M, an increase of 48680.49% from the same quarter last year. In Q4, Protagonist Therapeutics's net income was $27.34M. See Protagonist Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 60.00M	$ 60.00M	$ 26.58M	$ 91.00K	$ 28.63M	$ 231.00K
Cost of Revenue	-	-	-	-	-	-
Gross Profit	$ 60.00M	$ 60.00M	$ 123.00K	$ 91.00K	-	-
Operating Expense	$ 81.61M	$ 153.65M	$ -157.95M	$ 153.20M	$ 93.14M	$ 80.75M
Operating Income	$ -93.65M	$ -93.65M	$ -157.95M	$ -153.20M	$ -64.52M	$ -80.52M
Net Non Operating Interest Income Expense	$ 14.90M	$ 14.90M	$ 4.06M	$ 443.00K	$ 302.00K	$ 2.64M
Other Income Expense	$ 201.00K	$ 201.00K	$ -26.50M	$ -27.21M	$ -631.00K	$ -1.00K
Pretax Income	$ -78.95M	$ -78.95M	$ -127.39M	$ -125.55M	$ -64.84M	$ -77.88M
Tax Provision	-	-	-	-	$ 1.30M	$ -691.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -78.95M	$ -78.95M	$ -127.39M	$ -125.55M	$ -66.15M	$ -77.19M
Basic EPS	$ -1.48	$ -1.39	$ -2.60	$ -2.71	$ -1.92	$ -2.98
Diluted EPS	$ -1.48	$ -1.39	$ -2.60	$ -2.71	$ -1.92	$ -2.98
Basic Average Shares	$ 227.05M	$ 56.76M	$ 49.04M	$ 46.32M	$ 34.40M	$ 25.89M
Diluted Average Shares	$ 227.05M	$ 56.76M	$ 49.04M	$ 46.32M	$ 34.40M	$ 25.89M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 81.61M	$ 153.65M	$ -157.95M	$ 153.20M	$ 93.14M	$ 80.75M
Net Income From Continuing And Discontinued Operation	$ -78.95M	$ -78.95M	$ -127.39M	$ -125.55M	$ -66.15M	$ -77.19M
Normalized Income	$ -35.73M	$ -62.37M	-	-	$ -65.72M	$ -77.19M
Interest Expense	-	-	-	-	$ 598.00K	$ 169.00K
EBIT	$ -78.95M	$ -78.95M	$ -127.39M	$ -125.55M	$ -64.25M	$ -77.71M
EBITDA	$ -80.21M	$ -80.21M	$ -124.57M	$ -120.95M	$ -61.52M	$ -75.21M

Currency in USD

Protagonist Therapeutics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing